Skip to main content
. 2001 Sep;134(2):353–358. doi: 10.1038/sj.bjp.0704248

Figure 1.

Figure 1

Inhibition of platelet aggregation in whole blood in vitro by AR-C69931 (ARC 100 nmol l−1), dipyridamole (dip 10 μmol l−1), aspirin (ASA 100 μmol l−1) and combinations of these. (a) Spontaneous aggregation; (b) with 3 μmol l−1 ADP; (c) with 1 μmol l−1 PAF. Percentage of platelet aggregation is shown (mean±s.d.), n=6, *P<0.01.